Data as of Jan 30
| -0.06 / -0.92%|
The 6 analysts offering 12-month price forecasts for Evoke Pharma Inc have a median target of 18.50, with a high estimate of 30.00 and a low estimate of 14.00. The median estimate represents a +185.94% increase from the last price of 6.47.
The current consensus among 6 polled investment analysts is to Buy stock in Evoke Pharma Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.